I'm the editor of UK Value Investor, an investment website and newsletter for defensive value investors. I have been an investor since the 1990s and since 2010 I have been developing and applying a "defensive value" approach to building a high yield, low risk share portfolio.
This strategy is unique in that it focuses on a series of quantitative financial measures that look back through 10 years of financial results to find companies that have the best combination of quality and growth at the best prices.
I also write the blog at UKValueInvestor.com, and occasionally publish other content such as guides and spreadsheets.
Having left school at 16, I trained as a mechanical engineer but later switched to a career in insurance software. That lasted for more than a decade until I started my newsletter business in 2011.
My book, “The Defensive Value Investor”, covers my investment strategy in detail.
Over 30 years of investing in individual stocks. Extensive business experience with small to mid-size companies, including as CEO. Many hundreds of blog posts on financial and economic matters since 2008. Focus on value with catalysts for upside price action. Background as a physician and pharmaceutical inventor and entrepreneur, however focus now is global and involves almost all economic categories.
ValueWalk has gained popularity among all circles for its breaking stories on hedge funds, and investigative reports on investments by major funds.
NOTE we do not read comments or direct messages - please contact us via email if this is important
I've been contributing to SA since 2011, with a break to join the PRO editorial team from 2013-2015. I got my Series 7 and 63 back in 2000, and watched the dot-com bubble peak and then burst in real time at a small, tech-focused retail brokerage in NYC.
The Insiders Forum is brought to you by Bret Jensen, one of SeekingAlpha's most followed contributors and author of The Biotech Forum which is is the second most subscribed to service of the over 60 available via the MarketPlace.
Insiders Forum will be strictly focused on small and mid-cap stocks that insiders are buying. Some studies have shown that equities with heavy insider purchases outperform the overall market over time. The Insiders Forum will consist of my 15 top small and mid-sized stocks in different sectors of the market that are not only are attractively valued but have had some significant insider purchases in recent months.
We will build out an optimized 15 stock portfolio one stock at a time and track performance using a hypothetical $150,000 portfolio. The Insider Forum will feature bi-weekly portfolio updates as well as least one exclusive article a week on stocks with recent insider buying. Deep and exclusive analysis will be provided on all new additions to the portfolio. Our goal will be to outperform the Russell 2000 over time and the Insiders Forum's portfolio will be benchmarked against.
Our goal is to outperform the Russell 2000 over time as well as to be a sounding board for new investments in attractively priced equities where insiders are stepping up to the plate.
I am a medical professional, but I have been studying investing for many years so that I can control my own portfolio. DGI seems to be the best way for me to invest for my retirement while being able to sleep at night.
I have also been successfully trading cash secured puts for extra income. I share my experience on my websites, Tradingcsps.com and my blog Tradingputs.com.
Ian Bezek worked for 3 years as an analyst at a New York-based hedge fund. He's currently living in Mexico, pursuing some entrepreneurial opportunities.
Feel free to contact him regarding investments, writing, or speaking opportunities.
Mr. Sacks runs Grand Slam Asset Management, LLC, a registered investment adviser specializing in small and micro-cap value investing. Mr. Sacks unique combination of direct experience in company management, operations and finance allows him to identify undervalued and mispriced companies.
Prior to founding Grand Slam Asset Management, LLC, Mr. Sacks spent nine years at TSR Wireless (“TSR”), the nation’s fifth largest wireless messaging company and largest independent wireless retailer, rising from Vice President of Finance to Chief Financial Officer and ultimately Chief Executive Officer. Mr. Sacks completed various transactions, including mergers and acquisitions, private equity and debt financings.
Prior to joining TSR, Mr. Sacks gained experience in the financial markets while acting as an Account Executive with Merrill Lynch, an Investment Banker with Bankers Trust Company and Segal and Company, and as a Debt Portfolio Manager with Banque Francaise du Commerce Exterieur.
Mr. Sacks has a BA in Economics from Cornell University and a MBA in Finance from the New York University Graduate School of Management.
Executive with Merrill Lynch, an Investment Banker with Bankers Trust Company and Segal and Company, and as a Debt Portfolio Manager with Banque Francaise du Commerce Exterieur.
Mr. Sacks has a BA in Economics from Cornell University and a MBA in Finance from the New York University Graduate School of Management.
I am a psychologist at the University of Massachusetts/Amherst. I am on our campus’s Institutional Review Board, which must conclude that proposed studies involving human subjects are conducted ethically and are designed well enough so that any risks involved are justified by the likely benefits obtained.
I teach about analytical reasoning, leadership skills, reconciling apparently incompatible positions, designing, implementing, and evaluating policies, and how to critically evaluate competing health claims based on the samples studied and methods of data collection and analysis used.
Most of my investments involve owning medical industry stocks.
I'm a Managing Director at A North Investments (ANI), a quantitative hedge fund based in New York. Those who'd like to contact me, private message me here or email me at email@example.com.
To follow me click the "Follow" button! (Easy right?)
Kumquat Research is a college student and fund manager who has been investing for 4 years. He writes mostly about the technology sector and about event-driven and momentum opportunities across various industries and sectors. He is currently studying for degrees in both finance and computer science at the University of Maryland. Some of his interests include technology, programming, drumming, video games (developing and playing) and astronomy. Articles written and comments posted by Kumquat Research are NOT financial or investment advice, and only express his opinion. Do your own due diligence!
I am a fee-only fiduciary specializing in conscientious retirement planning and retirement income management with an internet practice serving clients around the country and internationally. ¶ An RMA® myself, I teach the Retirement Income Industry Association (http://riia-usa.org) RMA designation class to financial advisors through Salem State University. ¶ The RMA method uses your household balance sheet to build a safe retirement allocation to Upside/ Floor/ Longevity/ Reserves that puts securing your lifestyle ahead of schemes to "beat the market." ¶ Allocation to Floor and Upside is based on the strength of your balance sheet instead of ion arbitrary glide paths or monte carlo probability results. Its your life, not a game of chance. Better planning = a better outcome. ¶ I have developed an Excel based tool call R-MAP Planner for retirement planning that sets up the retirement allocations to the four risk management portfolios based on the strength of your household balance sheet. ¶ R-MAP is available at www.remap-planner.com. You can contact me at firstname.lastname@example.org
Cabeza Howe holds two M.S. degrees in engineering. He has extensive career background in science, engineering and software development. He is a self-made financial analyst and manages his own investment as a business. Focused value investing is his passion. He coined the term "two-in-one" stocks to describe stocks with both growth and value characteristics. He believes in achieving exceptional long-term return through investing in those stocks.
Through lessons learned and experience gained over the years, Cabeza believes the "two-in-one" stocks should be found mainly in large and mid caps. He views small caps as unproven and prone to perpetual decline even following days of glory. So he mostly believes trading instead of investing in small caps, with only rare exceptions.
He was born and grown up in China and used to trade and write about Chinese small caps. He now thinks Chinese small caps are in particular an area to avoid due to the well known accounting issues. The way Chinese regulators handled these accounting issues along with reported wealth of high ranking officials also convinced him that China is to an alarming degree ruled by kleptocracy. From first hand knowledge, however, Cabeza is still a big believer in Chinese consumers. He thinks the best way to benefit from it is through investing in multinationals like YUM, MCD, NKE, DIS and AAPL.
I'm an investor and a Chartered Business Valuator (CBV). I have been investing since I was a teenager. I love my work. I manage a private investment company and I specialize in business valuation.
I'm a huge skeptic by nature. If you had to put me in an investment category, I would fall under "contrarian/value" investor. It's not an investment style that I picked but one that reflects my personality.
Regarding my articles, I think to present my ideas present in a neutral light, without any hype or promotion, which is a rare thing these days.
Please note that any articles or comments on Seeking Alpha are not linked to my work, and the opinions or content mentioned are mine personally.
Get the highest conviction investment ideas from the world's greatest ideas for $12 per month. The Superinvestor Bulletin builds a portfolio exclusively from the highest conviction investments made by the world’s greatest investors. Since the world’s greatest investors tend to return 15 to 20 percent per year on average, replicating their best ideas should provide superior returns (without their egregious performance fees).Two full investment ideas per month (15 to 20 page report) plus weekly updates. Visit our website or contact us directly for a free sample report.
I've been trying my hand at investing for a long time and I'm just looking for an outlet for my views. I mainly go long, as I've been most successful doing that, however, I will go short if I see an extremely mispriced opportunity. I am contrarian usually, and am a long term holder.
Former broker, now an independent analyst/writer on Seeking Alpha and founder and editor of the Growth Stock Forum. Focusing on small-cap, mid-cap and biotech stocks. Looking for substantial sales and earnings growth potential and seeking the best risk-adjusted returns from my stock selection. Taking advantage of medium to long-term momentum.
My articles represent my personal opinion and analysis and should not be regarded as investment advice in any way. Readers and subscribers should do their own due diligence and/or consult their financial advisor before making decisions to buy or sell securities. Trading and investing include risks, including loss of principal.
Exclusive research: http://seekingalpha.com/author/oneil-trader/research
Looking for the value plays in the market. Offering easy to understand analysis usually on a macro level. Despite the efficiencies of the market, value plays are there every day; you just need to work to find them.
Tech Analyst and opportunistic investor focused primarily on micro caps and up and coming technology companies. I am currently in discussions with a partner to develop and launch a investment premium newsletter website. If you are interested in learning more about my premium newsletter or would like to be added to my mailing list you can inbox me.
You can follow my personal trades and invest your own money with me via Instavest www.instavest.com My focus is on ground breaking technology and the companies that will deliver them in the future. I have managed a family portfolio since 2008 that has been focused on growth and income generation. You can follow me on twitter @MattMargolis24
Current MBA candidate and graduate student. CPA and former external auditor at a Big Four public accounting firm. Occasional investor looking for early entry in growth opportunities.
My extensive experience working overseas has provided a solid foundation for my investment philosophy.
I have found that travel is a far better teacher than a conventional education. The experiences and knowledge one gains on the ground around the world cannot be taught in any classroom.
Retired Pharmacist. Call me Rose. Nose= Knows enough to know I need to keep learning and keeping a great dividend paying nest egg growing upwards. I also enjoy total return, but it is not my primary goal, it just happens to follow when buying great quality companies.
My 88 stock portfolio is listed here by sector, largest holding by value is listed first. Updated 10/20/2016.
Consumer Defensive (15): KO, PM, GIS, MO, TGT, KMB, CVS, DEO, PG, PEP, MDLZ, CL, KHC, UL. RAI -
Consumer Cyclical (8): MCD, SBUX, GPC, NKE, HAS, MAT, VFC, HD -
Healthcare (7): JNJ, ABBV, AMGN, CAH, BDX , GILD, PFE-
Energy (4): XOM, CVX, OXY, VLO, -
Tech (2): ADP, CSCO -
Industrial(8): BA, UNP, MMM, CMI, GWW, LMT. -
Financial (8): NRZ, ARI,, LADR, BXMT (mREITs) TROW, MA, V, WFC,
MET , CTO -
BDCs (7): ARCC, MAIN, PNNT, HTGC, NEWT (small), PSEC, GAIN -
REAL ESTATE or
Healthcare eREITs (5) : OHI, VTR, HCN, NHI, CCP, -
Equity Reits (12): WPC, DLR, O, CLDT, STAG, LXP, UBA, SNR (small), APLE, SPG, NSA -STWD (hybrid)
Telecom (2): VZ and T -
Utility (10): SO, D, XEL, MGEE, WEC, DNP, LNT, CNP, EXC, FE -
DNP is a CEF which predominately holds Utilities.
On October 31st, 2014, I retired. Turned in the keys to the company car, gave them my computer and my account lists and joined the ranks of those who "slipped off into the sunset." I never thought in retirement that I would be this busy. It's fun. Time with the grandkids, time to perfect my cooking skills, and time to travel and check off the things on my bucket list. I should have done this a long time ago.
I've developed personal investing strategies for individual stocks and Asset Allocation:
1) Stocks - Fundamental value investor using Free Cash Flow as defined by Buffett's 1987 shareholder letter. Invest in predictable, undervalued stocks with good management. Buy with a Margin of Safety, Sell at Intrinsic Value. Hold cash when nothing is available at my price. Use the Kelly Formula to determine optimum fraction to invest in each stock which maximizes the amount of money you win over a lifetime of investing.
2) Asset Allocation (for 401-k, small IRA accounts, and available cash) - Use a 'Value-Weighted' asset allocation strategy with inputs of projected returns/historic volatility. Apply the Kelly Formula to determine optimal asset allocation. Rebalance twice a year in April and October.
Store my portfolio - and my brain - on the web at www.healthywealthywiseproject.com
Stone Fox Capital Advisors is a registered investment advisor founded in 2010. The firm offers portfolio management with a focus on opportunistic stocks providing secular growth trends at an affordable value. An emphasis is placed on fundamental analysis though charts are used for timing entry and exit points.
Mark Holder graduated from the University of Tulsa with a double major in accounting & finance. He's been interested in the stock market since college and began managing investments for friends and family more than 20 years ago. Mark has his Series 65 and is also a CPA.
Invest with Stone Fox Capital's model portfolios on Covestor.com as he makes real time trades. Covestor also allows followers to duplicate the model portfolio in their own brokerage accounts. You can find the portfolio and more details here:
Follow Mark on twitter: @stonefoxcapital
I'm 32, invest in the light of the Austrian economic tradition, which in today's environment means mostly precious metals and mining stocks using cycles and sentiment as timing mechanisms. ETF's, options, I also own some physical. I've been doing this independently for 3 years. I reserve a small chunk of my portfolio for speculating in biotech and technology where I believe appropriate.